Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Not yet recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Interventions

Specimen Handling 65 Magnetic Resonance Spectroscopy 44 Cyclophosphamide 32 Carboplatin 31 Gemcitabine 30 Biopsy 28 Cisplatin 25 Bevacizumab 25 Radiotherapy 24 pembrolizumab 23 Paclitaxel 23 Standard of Care 22 Oxaliplatin 22 fludarabine 21 Nivolumab 21 Drug Therapy 21 Capecitabine 21 venetoclax 20 Interviews as Topic 18 Injections 17 Radiosurgery 16 Blood Specimen Collection 16 toripalimab 15 cemiplimab 15 Dexamethasone 15 Azacitidine 15 tislelizumab 14 Irinotecan 14 Docetaxel 14 anlotinib 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Not yet recruiting × penpulimab × 90 days × Clear all

NCT07612098 2026-05-28

SPARE-04

Cancer Institute and Hospital, Chinese Academy of Medical Sciences

Phase 2 Not yet recruiting

Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡